Class 2 Medicines Recall: Abstral 200microgram sublingual tablets (Kyowa Kirin)

Class 2 Medicines Recall: Abstral 200microgram sublingual tablets (Kyowa Kirin)

July 29, 2020

Class 2 MHRA medicines recall – Abstral 200microgram sublingual tablets (Kyowa Kirin)

Drug alert number: EL (20)A/34

Date issued: 29 July 2020

The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:

Abstral 200microgram sublingual tablets PL 16508/0031

Kyowa Kirin Limited is recalling the above batch as a precautionary measure, due to the reports of double tablets in a single blister pocket. This was identified during reference sample inspection and there is a potential low risk of accidental double dosage.

Batch Number Expiry Date Pack Size  First Distributed
608777302 31 July 2021 30 Tablets 24 December 2019

Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Further information

Full drug alert can be viewed here.

For Stock control enquiries please contact: Stuart Hay, Commercial Director

For Medical information enquiries please contact:

For Quality information please contact: Martin Smith (Responsible Person)


Posted in:

More Latest News >

PQS: AMS virtual event now on-demand

Community pharmacy contractors can now access an online recording of the antimicrobial stewardship (AMS) virtual event, which was jointly hosted...

Evaluation of LFD tests

As part of meeting Medicines and Healthcare products Regulatory Agency (MHRA) obligations, the UK Health Security Agency (UKHSA) – of...